Stock Groups

U.S. securities regulator charges Chicago medical professor with insider trading -Breaking

by Mike Robinson

[ad_1]

© Reuters. REUTERS/Jonathan Ernst

WASHINGTON (Reuters) – On Monday, the U.S. Securities and Exchange Commission accused a Chicago-based medical school professor of insider trading in securities belonging to biotechnology company Five Prime Therapeutics.

SEC claimed that Daniel V.T. Catenacci bought shares in the biotechnology firm ahead of an October 10, 2020 announcement that positive trial results had been obtained for a new cancer drug. Catenacci is alleged to have obtained nonpublic material about positive drug trials through his role of lead clinical investigator.

Catenacci was not available for comment immediately.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]